Osteoporosis is a health condition that weakens bones, making them fragile and more likely to break. It develops slowly over several years as our bone remodelling process slows down as a natural part of ageing. Often going unnoticed until a fall or sudden impact results in a break, osteoporosis can affect mobility and quality of life. Osteoporosis affects over 3 million people in the UK and over 500,000 people receive hospital treatment for fragility fractures every year as a result of osteoporosis.
Anyone can suffer from osteoporosis but women are about four times more likely than men to develop it, according to the online arthritis forum Versus Arthritis. The process of bone loss speeds up for several years after the menopause, when the ovaries stop producing oestrogen and men generally reach a higher level of bone density before the process of bone loss begins.
The stage before osteoporosis is called osteopenia. This is when a bone density scan shows lower than average bone density, but not low enough to be diagnosed as osteoporosis. Osteopenia does not always lead to osteoporosis. MBST® magnetic resonance therapy has been shown to help encourage bone density.
Initial treatment for osteoporosis is set on preventing broken bones by making positive changes to diet, taking regular exercise, in particular resistance training, and supplementing diet with vitamin D andCalcium. All have been shown to help, especially during the early stages of menopause.
Medically, bisphosphonates, SERMs, parathyroid and Hormone Replacement Therapy are some of the common treatments, however these treatments can result in unwanted side-effects such as joint or muscle pain, nausea and other gastrointestinal complaints.
MBST® therapy used in conjunction with physiotherapy and strengthening exercises is designed to encourage bone metabolism to help stimulate normal cell function, thereby reducing the risk of fractures. Research provides the evidence that MBST® magnetic resonance therapy can be beneficial in reducing the risk of bone fractures in osteoporotic patients.